Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thiamin pyrophosphokinase (TPK) is an enzyme that catalyzes the transfer of a pyrophosphate group from ATP to thiamin (vitamin B1) to form thiamin pyrophosphate (TPP)[1][2][3]. TPP is essential as a coenzyme for multiple metabolic enzymes, including pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, and transketolase, which are crucial for central energy metabolism[1][2]. Deficiency of thiamin or impairment of TPK function leads to severe neurological and cardiovascular disorders, such as Wernicke-Korsakoff syndrome and beriberi[1][2]. TPK operates as a dimer (and possibly tetramer) and shows a structural motif similar to the Rossmann fold, classifying it within the pyrophosphotransferase family[1][2][3].
Catalyzes pyrophosphate transfer from ATP to thiamine, producing TPP (coenzyme for key metabolic enzymes)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thiamin pyrophosphokinase (TPK).